Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive disease

被引:4
作者
Cunha, Alyne Conduru dos Santos [1 ]
Simon, Adrian Georg [1 ]
Zander, Thomas [3 ]
Buettner, Reinhard [1 ]
Bruns, Christiane Josephine [2 ]
Schroeder, Wolfgang [2 ]
Gebauer, Florian [2 ]
Quaas, Alexander [1 ]
机构
[1] Univ Cologne, Univ Hosp Cologne, Inst Pathol, Med Fac, Kerpener Str 62, DE-50937 Cologne, Germany
[2] Univ Cologne, Univ Hosp Cologne, Med Fac, Dept Gen Visceral & Canc Surg, Cologne, Germany
[3] Univ Cologne, Univ Hosp Cologne, Med Fac, Dept Internal Med 1, Cologne, Germany
关键词
Esophageal cancer; Esophageal adenocarcinoma; Mast cells; Tumor microenvironment; Natural killer cells; Tumor immune environment; PLASMA-CELLS; CANCER; SURVIVAL; EPIDEMIOLOGY; CARCINOMA; DIAGNOSIS; DENSITY; ROLES;
D O I
10.1007/s00432-023-04650-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeEsophageal adenocarcinoma (EAC) remains a challenging and lethal cancer entity. A promising target for new therapeutic approaches, as demonstrated by the success of immune checkpoint inhibitors, are tumor-associated immune cells and the tumor microenvironment (TME). However, the understanding of the TME in esophageal cancer remains limited and requires further investigation.MethodsOver 900 EAC samples were included, including patients treated with primary surgery and neoadjuvant (radio-)chemotherapy. The immune cell infiltrates of mast cells (MC), natural killer cells (NK cells), plasma cells (PC), and eosinophilic cells (EC) were assessed semi-quantitatively and correlated with histopathological parameters and overall survival (OS).ResultsA high presence of all four immune cell types significantly correlated with a less extensive tumor stage and a lower frequency of lymph node metastasis, and, in case of NK cells, with less distant metastasis. The presence of MC and NK cells was favorably associated with a prolonged OS in the total cohort (MC: p < 0.001; NK cells: p = 0.004) and patients without neoadjuvant treatment (MC: p < 0.001; NK cells: p = 0.01). NK cells were a favorable prognostic factor in the total cohort (p = 0.007) and in the treatment-naive subgroup (p = 0.04). Additionally, MC were a favorable prognostic factor in patients with lymph node metastasis (p = 0.009).ConclusionOur results indicate a complex and important role of mast cells, NK cells, and the other assessed immune cells in the tumor microenvironment of EAC. Therefore, they are one further step to a better understanding of the immune cell environment and the potential therapeutic implications in this cancer entity.
引用
收藏
页码:6917 / 6929
页数:13
相关论文
共 44 条
  • [1] NF-κB activation in Esophageal adenocarcinoma -: Relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy
    Abdel-Latif, MMM
    O'Riordan, J
    Windle, HJ
    Carton, E
    Ravi, N
    Kelleher, D
    Reynolds, JV
    [J]. ANNALS OF SURGERY, 2004, 239 (04) : 491 - 500
  • [2] The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma
    Al-Shibli, Khalid
    Al-Saad, Samer
    Donnem, Tom
    Persson, Magnus
    Bremnes, Roy M.
    Busund, Lill-Tove
    [J]. HISTOPATHOLOGY, 2009, 55 (03) : 301 - 312
  • [3] Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial
    Andre, Thierry
    Amonkar, Mayur
    Norquist, Josephine M.
    Shiu, Kai-Keen
    Kim, Tae Won
    Jensen, Benny Vittrup
    Jensen, Lars Henrik
    Punt, Cornelis J. A.
    Smith, Denis
    Garcia-Carbonero, Rocio
    Sevilla, Isabel
    de la Fouchardiere, Christelle
    Rivera, Fernando
    Elez, Elena
    Diaz Jr, Luis A.
    Yoshino, Takayuki
    Cutsem, Eric Van
    Yang, Ping
    Farooqui, Mohammed
    Le, Dung T.
    [J]. LANCET ONCOLOGY, 2021, 22 (05) : 665 - 677
  • [4] Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030
    Arnold, Melina
    Laversanne, Mathieu
    Brown, Linda Morris
    Devesa, Susan S.
    Bray, Freddie
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (08) : 1247 - 1255
  • [5] Sexual dimorphism in gastric cancer: tumor-associated neutrophils predict patient outcome only for women
    Clausen, Franziska
    Behrens, Hans-Michael
    Krueger, Sandra
    Roecken, Christoph
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (01) : 53 - 66
  • [6] Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO
  • [7] 2-P
  • [8] The roles of mast cells in anticancer immunity
    Dalton, Dyana K.
    Noelle, Randolph J.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (09) : 1511 - 1520
  • [9] ypT0N+: the unusual patient with pathological complete tumor response but with residual lymph node disease after neoadjuvant chemoradiation for esophageal cancer, what's up?
    Depypere, Lieven Peter
    Vervloet, Gil
    Lerut, Toni
    Moons, Johnny
    De Hertogh, Gert
    Sagaert, Xavier
    Coosemans, Willy
    Van Veer, Hans
    Nafteux, Philippe Robert
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (05) : 2771 - 2778
  • [10] Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence study
    Dijksterhuis, Willemieke P. M.
    Verhoeven, Rob H. A.
    Slingerland, Marije
    Mohammad, Nadia Haj
    de Vos-Geelen, Judith
    Beerepoot, Laurens, V
    van Voorthuizen, Theo
    Creemers, Geert-Jan
    van Oijen, Martijn G. H.
    van Laarhoven, Hanneke W. M.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (07) : 1889 - 1901